Vor bio reports second quarter 2024 financial results and provides company update

Cambridge, mass., aug. 08, 2024 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended june 30, 2024, and provided a corporate update.
VOR Ratings Summary
VOR Quant Ranking